INS and diabetes mellitus: The principle of subclassifying diabetes using genetics and applying this knowledge to guide therapeutic decision making has proof of principle in the monogenic form of diabetes called MODY, which is characterised by defects in the development of the pancreatic islet cells and insulin secretion.